Clinical Trial Update: A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers. [Phase 1]

View source ↗

Summary

Phase 1 study comparing concentrations of LY2189265 after different administration methods in healthy volunteers, sponsored by Eli Lilly, in the context of Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY2189265

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type II | Phase 1 | Status: COMPLETED | Results posted: 2014-10-07